Form 8-K - Current report:
SEC Accession No. 0001437749-24-037764
Filing Date
2024-12-18
Accepted
2024-12-17 19:20:50
Documents
22
Period of Report
2024-12-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K rvph20241217_8k.htm   iXBRL 8-K 43785
2 EXHIBIT 1.1 ex_758353.htm EX-1.1 240521
3 EXHIBIT 4.1 ex_758354.htm EX-4.1 117607
4 EXHIBIT 4.2 ex_758355.htm EX-4.2 118504
5 EXHIBIT 5.1 ex_758356.htm EX-5.1 12224
6 EXHIBIT 99.1 ex_758357.htm EX-99.1 11009
7 EXHIBIT 99.2 ex_758358.htm EX-99.2 11753
12 logo.jpg GRAPHIC 11540
13 rvph01.jpg GRAPHIC 8960
  Complete submission text file 0001437749-24-037764.txt   857328

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA rvph-20241216.xsd EX-101.SCH 3872
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvph-20241216_def.xml EX-101.DEF 13797
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvph-20241216_lab.xml EX-101.LAB 18159
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvph-20241216_pre.xml EX-101.PRE 13829
24 EXTRACTED XBRL INSTANCE DOCUMENT rvph20241217_8k_htm.xml XML 4842
Mailing Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014
Business Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38634 | Film No.: 241557267
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)